Erin Henderson - BWV Chief Sec
| BWV Etf | USD 1.12 0.04 3.45% |
| Age | 48 |
| Phone | 513 620 4101 |
| Web | https://www.bluewatervaccines.com |
BWV Management Efficiency
The company has Return on Asset of (0.3022) % which means that on every $100 spent on assets, it lost $0.3022. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.0163) %, meaning that it generated no profit with money invested by stockholders. BWV's management efficiency ratios could be used to measure how well BWV manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
| Showing other executives | One Year Return | ||
| Chester III | Revelation Biosciences | 45 | |
| MD MBA | Kiora Pharmaceuticals | 51 | |
| MPA MD | Unicycive Therapeutics | 52 | |
| John CPA | Unicycive Therapeutics | 63 | |
| Professor MD | Allarity Therapeutics | 67 | |
| MBA JD | Cardio Diagnostics Holdings | 60 | |
| Denise Carter | Quoin Pharmaceuticals Ltd | 56 | |
| Melissa Tosca | Kiora Pharmaceuticals | N/A | |
| MD DrSc | Allarity Therapeutics | 81 | |
| Claus Pedersen | Allarity Therapeutics | 52 | |
| James JD | Allarity Therapeutics | 55 | |
| MD FAAAAI | Palisade Bio | N/A | |
| Robert McRae | Palisade Bio | N/A | |
| Meeshanthini Dogan | Cardio Diagnostics Holdings | 36 | |
| Tomasz George | Virax Biolabs Group | 40 | |
| James Rolke | Revelation Biosciences | 56 | |
| James Foster | Virax Biolabs Group | 40 | |
| Timur Dogan | Cardio Diagnostics Holdings | 37 | |
| Carol Odle | Revelation Biosciences | N/A | |
| Brian Strem | Kiora Pharmaceuticals | 45 | |
| Michael Myers | Quoin Pharmaceuticals Ltd | 63 | |
Management Performance
| Return On Equity | -1.02 | |||
| Return On Asset | -0.3 |
BWV Money Managers
| Theodore Yoho, Head Devel | ||
| Erin Henderson, Chief Sec | ||
| Brian Price, Head Strategy | ||
| Andrew Skibo, Global Operations | ||
| Jon Garfield, Chief Officer | ||
| MBA MS, Pres CEO | ||
| Ronald Cobb, Head Discovery |
BWV Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BWV a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.02 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | 8.81 M | |||
| Shares Outstanding | 18.66 M | |||
| Shares Owned By Insiders | 17.69 % | |||
| Shares Owned By Institutions | 23.44 % | |||
| Number Of Shares Shorted | 23.33 K | |||
| Price To Book | 0.35 X | |||
| EBITDA | (13.54 M) | |||
| Net Income | (13.42 M) |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
The market value of BWV is measured differently than its book value, which is the value of BWV that is recorded on the company's balance sheet. Investors also form their own opinion of BWV's value that differs from its market value or its book value, called intrinsic value, which is BWV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BWV's market value can be influenced by many factors that don't directly affect BWV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BWV's value and its price as these two are different measures arrived at by different means. Investors typically determine if BWV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BWV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.